• Rhodamine B Workflows for Nanomedicine Imaging

  2026-08-14

  Rhodamine B combines practical solvent flexibility with strong utility as a cell-labeling fluorescent dye, making it useful for tracking nanoparticle uptake, tissue distribution, and fluorescence-based assay performance. This workflow-focused guide shows how to adapt Basic Violet 10 for imaging studies inspired by trypsin-responsive pancreatitis nanomedicine while separating validated findings from assay-development recommendations.

• Triple-Target Inhibition in BRAFV600E Melanoma

  2026-08-13

  This study shows that eIF4F inhibition alone can trigger compensatory ERK1/2, AKT1, and EZH2 signaling in BRAFV600E melanoma cells. Combining an eIF4F inhibitor with AKT1 and EZH2 blockade enhanced apoptosis, reduced proliferation, and restored sensitivity to eIF4F and BRAF inhibition in cellular and in vivo models.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-08-13

  Gu et al. show that palbociclib can inhibit pancreatic tumor cell growth while paradoxically intensifying migration, invasion, and epithelial-to-mesenchymal transition through GSK3β-mediated Wnt/β-catenin activation. BET inhibition with JQ1 counteracted these effects and produced synergistic antitumor activity in cell models and an orthotopic pancreatic cancer model, providing a mechanistic rationale for combination treatment.

• BMP4-GPX4 Protects RGCs in Glaucoma Models

  2026-08-12

  The reference study identifies the BMP4-GPX4 axis as a regulator of ferroptosis-associated retinal ganglion cell injury and as a potential enhancer of retinal stem cell differentiation after transplantation. Its integrated use of a mouse retinal injury model, transcriptomic analysis, redox measurements, and protein-level validation links oxidative stress and iron accumulation with a regenerative cell-therapy strategy.

• Tetracycline Hydrochloride: From Mechanism to Translation

  2026-08-12

  A translational strategy for using Tetracycline Hydrochloride in antimicrobial and skin microbiome research, while distinguishing its ribosomal mechanism from emerging ROS-driven cancer therapeutics.

• EdU Imaging Kits (HF594): Practical Workflow

  2026-08-11

  EdU Imaging Kits (HF594), SKU K2243, provide an endpoint method for measuring S-phase DNA synthesis through EdU incorporation and HyperFluor™ 594 click-chemistry detection. They are suitable for fluorescence microscopy and flow cytometry proliferation assays, but signal should not be interpreted as a direct measure of completed cell division, viability, or long-term growth without supporting controls.

• N1-Methylpseudo-UTP: A Translational Design Lever

  2026-08-11

  N1-Methyl-Pseudouridine-5'-Triphosphate can be more than an RNA synthesis reagent: it is a controllable variable in the design of stable, efficiently translated mRNA payloads. This thought-leadership analysis connects nucleotide chemistry with the antigen–adjuvant and delivery strategy demonstrated in a recent influenza mRNA lipid nanoparticle study.

• 740 Y-P: PI3K Activation Protocol and QC

  2026-08-10

  740 Y-P is a cell-permeable PI 3-kinase activator for controlled modulation of PI3K/AKT signaling in vesicular trafficking, survival, and cancer research workflows. It is suitable for exploratory cellular assays, but it should not be treated as a universal dose standard or used when ethanol-based formulation or long-term solution storage is required.

• CH 223191: Mapping AhR-Driven Ovarian Toxicity

  2026-08-09

  CH 223191 is a potent aryl hydrocarbon receptor antagonist for resolving how environmental ligands alter endocrine tissues. This guide translates ovarian follicle evidence into a pathway-centered assay strategy that distinguishes AhR engagement from nonspecific toxicity.

• Self-Amplifying RNA Vaccines for Seasonal Influenza

  2026-08-08

  This 2026 study shows that self-amplifying RNA can overcome the weak influenza B immunogenicity observed with conventional nucleoside-modified mRNA in mice. At a low dose, trivalent saRNA generated durable antibody responses and complete protection against influenza B challenge, highlighting platform- and subtype-specific determinants of RNA vaccine performance.

• Tivozanib (AV-951): Measure More Than Viability

  2026-08-07

  Tivozanib (AV-951) is a selective VEGFR inhibitor whose biology can be obscured by conventional viability assays. This guide connects VEGFR pathway pharmacology with a more rigorous framework for separating growth inhibition from true cell killing in oncology research.

• Radioiodinated Balsalazide: Advancing UC Imaging in Mice

  2026-08-07

  Sanad et al. present a robust protocol for radioiodinating balsalazide, yielding a highly selective, stable radiotracer for imaging ulcerative colitis (UC) in mice. Their work enables precise, extended biodistribution studies in preclinical UC models, addressing key shortcomings of prior radiotracers.

• H 89 2HCl: Precision PKA Inhibition in cAMP Signaling Assays

  2026-08-06

  H 89 2HCl empowers researchers to dissect cAMP/PKA signaling with high selectivity and reproducibility, as evidenced in studies on neuronal calcium modulation and protein phosphorylation. This article demystifies experimental workflows, protocol tuning, and troubleshooting strategies for leveraging H 89 2HCl in advanced cellular models.

• NMDA (N-Methyl-D-aspartic acid) in Advanced Excitotoxicity M

  2026-08-06

  Leverage NMDA (N-Methyl-D-aspartic acid) for highly reproducible modeling of excitotoxicity, ferroptosis, and neurodegeneration. This article delivers optimized protocols, troubleshooting essentials, and practical insights from cutting-edge glaucoma research to power your next neuroscience experiment.

• Pregnenolone Carbonitrile: Advanced Workflows in Hepatic and

  2026-08-05

  Pregnenolone Carbonitrile stands out as a versatile tool for dissecting PXR-mediated hepatic detoxification and unraveling glucocorticoid receptor-dependent neuroprotection. This article translates cutting-edge reference findings and best practices into actionable protocols, troubleshooting tips, and workflow innovations for biomedicine.

7962 records 2/531 page Previous Next 12345 下5页 Last page